Related Experiment Video

Updated: Aug 17, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Infectious diseases that result in slowly resolving and chronic pneumonia

D E Corley1, R H Winterbauer

  • 1Department of Internal Medicine, Virginia Mason Medical Center, Seattle, WA.

Seminars in Respiratory Infections
|March 1, 1993
PubMed

Insights

Understanding pneumonia resolution is key. Common pathogens like Streptococcus pneumoniae, not neoplasms, often cause slow-resolving pneumonia, guiding clinical evaluation and avoiding unnecessary invasive procedures.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Assessing pneumonia resolution rate is crucial for effective clinical management.
  • Slowly resolving pneumonia is often misattributed to neoplasm or uncommon pathogens.
  • Understanding the natural history of pneumonia aids in differentiating causes of delayed resolution.

Purpose of the Study:

  • To clarify the common causes of slowly resolving pneumonia.
  • To differentiate between typical and atypical causes of delayed pneumonia resolution.
  • To guide clinicians in managing patients with slowly resolving pneumonia and avoid premature invasive evaluations.

Main Methods:

  • Review of the natural history of common pneumonia pathogens.
  • Analysis of clinical presentations of slowly resolving pneumonia.
  • Comparison of resolution patterns for different causative agents of pneumonia.

Main Results:

  • Host factors and common pathogens (e.g., Streptococcus pneumoniae, Legionella pneumophila) are frequent causes of delayed pneumonia resolution.
  • Mycoplasma pneumoniae and Chlamydia species are rarely associated with slowly resolving pneumonia.
  • Chronic bacterial pneumonia presentations can mimic other serious conditions like neoplasm or interstitial lung disease.

Conclusions:

  • Clinicians should recognize that common pathogens, not necessarily neoplasms, are often responsible for slowly resolving pneumonia.
  • Familiarity with pneumonia resolution patterns can prevent unnecessary invasive diagnostic procedures.
  • Chronic bacterial pneumonia requires careful diagnosis due to its varied presentation.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...